Vertex Pharmaceuticals (VRTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known ...

After some hype and excitement about their first full season with Aaron Rodgers, the disorganized New York Jets are now facing disaster. With their 25-22 defeat to the mostly miserable New England ...

Cantopop’s “Four Heavenly Kings” all ventured into film with varying degrees of success. A great small-scale cops-and-triads crime thriller directed by Wu Ma and featuring Kwok, Waise Lee ...

At the heart of this biotech boom lies Vertex Pharmaceuticals, a trailblazer that has played a pivotal role in transforming medical landscapes and reshaping patient lives. From groundbreaking ...

Gena Wang, an analyst from Barclays, maintained the Hold rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price target remains the same with $509.00. Gena Wang has given ...

BOSTON - Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX) has released new data demonstrating significant progress in its clinical trials for kidney diseases, including IgA ...

So when a business like Vertex Pharmaceuticals (NASDAQ: VRTX) releases some new data on a potential blockbuster that could be just a few months away from being approved for sale, it's a big ...

Vertex has reported phase 3 data on its near-approval pain drug candidate suzetrigine, shedding light on how the non-opioid painkiller combines with ibuprofen and why the prospect failed to match ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...